Robotic repair of the tricuspid valve in a beating heart.
Intracardiac beating heart tricuspid valve repair via robotics.
This study is exploring a new robotic method to fix the tricuspid valve in people with heart valve problems, making it easier and safer than traditional surgery, especially for those who might be at higher risk.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Boston University (Charles River Campus) NIH-funded |
| Lab location | 1 site (Boston, United States) |
| Project ID | NIH-11047797 on NIH RePORTER |
What this research studies
This research focuses on developing a robotic approach to repair the tricuspid valve in patients with valvular heart disease. It aims to create a minimally invasive technique that can be performed without the complications associated with traditional open-heart surgery. By utilizing advanced robotics, the study seeks to address the unique challenges posed by the beating heart and the complex anatomy of the tricuspid valve. This innovative method could potentially allow high-risk patients to receive effective treatment without the need for extensive recovery times.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals suffering from tricuspid valve regurgitation, particularly those who are considered high-risk for traditional surgical interventions.
Not a fit: Patients with other types of heart valve diseases or those who are not candidates for any form of heart surgery may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could provide a safer and more effective treatment option for patients with tricuspid valve regurgitation.
How similar studies have performed: While robotic approaches in cardiac surgery are emerging, this specific application for tricuspid valve repair is relatively novel and has not been extensively tested in prior studies.
Where this research is happening
Boston, United States
- Boston University (Charles River Campus) — Boston, United States (Active)
Researchers
- Principal investigator: Ranzani, Tommaso — Boston University (Charles River Campus)
- Study coordinator: Ranzani, Tommaso
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.